Cover Image

A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism

Cancer stem cells (CSCs) have been blamed as the main culprit of tumor initiation, progression, metastasis, chemoresistance, and recurrence. However, few anti-CSCs agents have achieved clinical success so far. Here we report a novel derivative of lonidamine (LND), namely HYL001, which selectively an...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiang Wang (Author), Shiyou Li (Author), Chen Xu (Author), Ao Hua (Author), Chong Wang (Author), Yuxuan Xiong (Author), Qingyuan Deng (Author), Xiang Chen (Author), Tian Yang (Author), Jiangling Wan (Author), Ze-yang Ding (Author), Bi-xiang Zhang (Author), Xiangliang Yang (Author), Zifu Li (Author)
Format: Book
Published: Elsevier, 2023-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items